# Ad-HGF Treatment for Myocardial Infarction

Study · id `cardio:ct-nct02844283` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02844283](<https://clinicaltrials.gov/study/NCT02844283>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02844283

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02844283. Randomized; quadruple masking; primary purpose treatment. Start 2016-11 (registry gives no type); primary completion 2018-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02844283, source copy `cardio:ctgov-nct02844283-2016-07-26`, retrieved 2026-10-26)
- Start date: 2016-11 (registry gives no type) (ClinicalTrials.gov record NCT02844283, source copy `cardio:ctgov-nct02844283-2016-07-26`, retrieved 2026-10-26)
- Primary completion: 2018-07 (anticipated) (ClinicalTrials.gov record NCT02844283, source copy `cardio:ctgov-nct02844283-2016-07-26`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02844283-2016-07-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ad-HGF Treatment for Myocardial Infarction
- Condition: Myocardial Infarction
- Intervention (Drug): Ad-HGF
- Intervention (Other): 0.9% NaCl
- Lead sponsor: The First Affiliated Hospital with Nanjing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: The First Affiliated Hospital with Nanjing Medical University (`cardio:org-the-first-affiliated-hospital-with-nanjing-medical-898271`)

## Provenance

Content hash: dcb1dd88c4ce2e16b49a7aef121f0160410c7865f5e45022e8237f27aac9039d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
